Pigeaud, K.E.; Rietveld, M.L.; Witvliet, A.F.; Hogervorst, J.M.A.; Zhang, C.; Forouzanfar, T.; Bravenboer, N.; Schoenmaker, T.; de Vries, T.J.
The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts. Int. J. Mol. Sci. 2023, 24, 7574.
https://doi.org/10.3390/ijms24087574
AMA Style
Pigeaud KE, Rietveld ML, Witvliet AF, Hogervorst JMA, Zhang C, Forouzanfar T, Bravenboer N, Schoenmaker T, de Vries TJ.
The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts. International Journal of Molecular Sciences. 2023; 24(8):7574.
https://doi.org/10.3390/ijms24087574
Chicago/Turabian Style
Pigeaud, Karina E., Melanie L. Rietveld, Aster F. Witvliet, Jolanda M. A. Hogervorst, Chen Zhang, Tim Forouzanfar, Nathalie Bravenboer, Ton Schoenmaker, and Teun J. de Vries.
2023. "The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts" International Journal of Molecular Sciences 24, no. 8: 7574.
https://doi.org/10.3390/ijms24087574
APA Style
Pigeaud, K. E., Rietveld, M. L., Witvliet, A. F., Hogervorst, J. M. A., Zhang, C., Forouzanfar, T., Bravenboer, N., Schoenmaker, T., & de Vries, T. J.
(2023). The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts. International Journal of Molecular Sciences, 24(8), 7574.
https://doi.org/10.3390/ijms24087574
